LMAT vs SGEN
LeMaitre Vascular Inc (LMAT) versus SGEN (SGEN) — a side-by-side from cached financials, not a winner call.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
SGEN (SGEN) common stock.
Latest reported LMAT revenue for 2026-06-30 was $136.9M. Net income was $32.7M. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
SGEN does not have a complete income-statement cache yet.
LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the LMAT and SGEN stock pages for the full models.
Not investment advice.